H2020FP7HORIZON
Janssen Pharmaceutica NV
- Country
- BEBelgium
- Defence projects
- 0
- Projects, all programmes
- 131
- As coordinator
- 6
- EU contribution (CORDIS)
- EUR 10,443,749
- Active
- 2008 to 2025
Projects
131 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| ConcePTIONBuilding an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation | H2020 | 2019 | Participant | EUR 0 |
| LongActNowLong Acting Medicines for Complex Therapeutics Needed Now | H2020 | 2019 | Participant | EUR 512,640 |
| MELLODDYMachinE Learning Ledger Orchestration for Drug DiscoverY | H2020 | 2019 | Participant | EUR 0 |
| EBiSC2EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells | H2020 | 2019 | Participant | EUR 0 |
| MatheGramMultiscale Analysis of Thermomechanical Behaviour of Granular Materials | H2020 | 2019 | Partner | EUR 0 |
| NEURONETEfficiently Networking European Neurodegeneration Research | H2020 | 2019 | Participant | EUR 0 |
| IM2PACTInvestigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain | H2020 | 2019 | Participant | EUR 0 |
| COMBINECollaboration for Prevention and Treatment of MDR Bacterial Infections | H2020 | 2019 | Participant | EUR 0 |
| TransBioLineTranslational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease | H2020 | 2019 | Participant | EUR 0 |
| RespiriNTMProgress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline | H2020 | 2019 | Participant | EUR 0 |
| 3TRIdentification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions | H2020 | 2019 | Participant | EUR 0 |
| Trials@HomeTrials@Home: Center of Excellence – Remote Decentralised Clinical Trials | H2020 | 2019 | Participant | EUR 0 |
| IMMUcanIntegrated IMMUnoprofiling of large adaptive CANcer patients cohorts | H2020 | 2019 | Participant | EUR 0 |
| VALUE-DxThe value of diagnostics to combat antimicrobial resistance by optimising antibiotic use | H2020 | 2019 | Participant | EUR 0 |
| FAIRplusFAIRplus | H2020 | 2019 | Participant | EUR 0 |
| AIMS-2-TRIALSAutism Innovative Medicine Studies – 2 – Trials | H2020 | 2018 | Participant | EUR 0 |
| ESCulabEuropean Screening Centre; Unique Library for Attractive Biology | H2020 | 2018 | Participant | EUR 0 |
| PIONEERProstate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope | H2020 | 2018 | Participant | EUR 0 |
| PARADIGMPatients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. | H2020 | 2018 | Participant | EUR 0 |
| c4cconect4children (COllaborative Network for European Clinical Trials For Children) | H2020 | 2018 | Participant | EUR 0 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.